Terramycin-Polymyxin B 30 mg/ g / 10000 IE/ g Norge - norsk - Statens legemiddelverk

terramycin-polymyxin b 30 mg/ g / 10000 ie/ g

pfizer as - oksytetrasyklinhydroklorid / polymyksin b sulfat - salve - 30 mg/ g / 10000 ie/ g

Zeldox 80 mg Norge - norsk - Statens legemiddelverk

zeldox 80 mg

pfizer as - ziprasidonhydrokloridmonohydrat - kapsel, hard - 80 mg

Lorviqua Den europeiske union - norsk - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - karsinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Vizimpro Den europeiske union - norsk - EMA (European Medicines Agency)

vizimpro

pfizer europe ma eeig - dacomitinib monohydrat - karsinom, ikke-småcellet lunge - antineoplastiske midler - vizimpro, som monoterapi er indisert for det første-linje behandling av voksne pasienter med lokalt avansert eller metastatisk ikke-liten celle lunge kreft (nsclc) med epidermal vekstfaktor reseptor (egfr) aktiverende mutasjoner.

Daurismo Den europeiske union - norsk - EMA (European Medicines Agency)

daurismo

pfizer europe ma eeig - glasdegib maleate - leukemi, myeloid, akutt - antineoplastiske midler - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Litfulo Den europeiske union - norsk - EMA (European Medicines Agency)

litfulo

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunsuppressive - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Arthrotec 50 mg / 0.2 mg Norge - norsk - Statens legemiddelverk

arthrotec 50 mg / 0.2 mg

pfizer as - diklofenaknatrium / misoprostol - tablett med modifisert frisetting - 50 mg / 0.2 mg

Depo-Provera 150 mg/ ml Norge - norsk - Statens legemiddelverk

depo-provera 150 mg/ ml

pfizer as - medroksyprogesteronacetat - injeksjonsvæske, suspensjon - 150 mg/ ml

Fragmin 25000 IE anti-Xa/ ml Norge - norsk - Statens legemiddelverk

fragmin 25000 ie anti-xa/ ml

pfizer as - dalteparinnatrium - injeksjonsvæske, oppløsning - 25000 ie anti-xa/ ml

Fragmin 12500 IE anti-Xa/ ml Norge - norsk - Statens legemiddelverk

fragmin 12500 ie anti-xa/ ml

pfizer as - dalteparinnatrium - injeksjonsvæske, oppløsning - 12500 ie anti-xa/ ml